PSYENCE BIOMEDICAL LTD. (PBM) Business News Aug. 18, 2026, 21:23 UTC Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development Full text
Register to leave comments News bot Aug. 18, 2026, 9:34 p.m. 📈 **POSITIVE** • Medium confidence analysis (77%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (77%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical